{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:17:25Z","timestamp":1785788245972,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1097\/01.fpc.0000114764.78957.22","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T04:01:55Z","timestamp":1090987315000},"page":"549-556","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humans"],"prefix":"10.1097","volume":"14","author":[{"given":"Kaoru","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Wanibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Urae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210213","first-page":"115","article-title":"The metabolism of methylphenobarbitone in man.","volume":"1","author":"Kunze","year":"1980","journal-title":"Asean J Clin Sci"},{"key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007691-198109000-00004","article-title":"Pharmacokinetics and bioavailability of methylphenobarbital in man.","volume":"3","author":"Hooper","year":"1981","journal-title":"Ther Drug Monit"},{"key":"R3-8-20210213","first-page":"381","article-title":"Qualitative and quantitative studies of methylphenobarbital metabolism in man.","volume":"9","author":"Hooper","year":"1981","journal-title":"Drug Metab Dispos"},{"key":"R4-8-20210213","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.1985.196","article-title":"Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.","volume":"38","author":"Kupfer","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R5-8-20210213","first-page":"212","article-title":"Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.","volume":"17","author":"Lim","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"R6-8-20210213","first-page":"36","article-title":"Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.","volume":"29","author":"Kobayashi","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"R7-8-20210213","first-page":"1429","article-title":"Role of human CYP2B6 in S-mephobarbital N-demethylation.","volume":"27","author":"Kobayashi","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R8-8-20210213","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/jnci\/84.22.1744","article-title":"Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamide.","volume":"84","author":"Boddy","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"R9-8-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.tpj.6500157","article-title":"Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.","volume":"3","author":"Xie","year":"2003","journal-title":"Pharmacogenom J"},{"key":"R10-8-20210213","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in human CYP2B6 gene with impact on expression and function in human liver.","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.103.054866","article-title":"Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.","volume":"307","author":"Lamba","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008571-200310000-00005","article-title":"Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.","volume":"13","author":"Kirchheiner","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R14-8-20210213","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(96)90214-3","article-title":"Genotyping of S-mephenytoin 4-hydroxylation in an extended Japanese population.","volume":"60","author":"Kubota","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R15-8-20210213","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00228-002-0499-5","article-title":"Allele and genotype frequencies of CYP2B6 and CYP3A5 in Japanese population.","volume":"58","author":"Hiratsuka","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-8-20210213","first-page":"131","article-title":"Preliminary observations on the pharmacokinetics of methylphenobarbitone.","volume":"15","author":"Eadie","year":"1978","journal-title":"Clin Exp Neurol"},{"key":"R18-8-20210213","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1006\/bbrc.2001.4524","article-title":"A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation.","volume":"281","author":"Ariyoshi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R19-8-20210213","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/dmd.31.4.398","article-title":"Functional characterization of cytochrome P450 2B6 allelic variants.","volume":"31","author":"Jinno","year":"2003","journal-title":"Drug Metab Dispos"}],"container-title":["Pharmacogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.fpc.0000114764.78957.22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:22:44Z","timestamp":1785784964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008571-200408000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000114764.78957.22","relation":{},"ISSN":["0960-314X"],"issn-type":[{"value":"0960-314X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}